Skip to main content
. 2012 Dec 19;7(12):e48291. doi: 10.1371/journal.pone.0048291

Figure 6. Dual treatment protocols.

Figure 6

Cell survival following dual treatment protocols with doxorubicin (1 µM) and ultrasound (0.4 W/cm2). (a) Simultaneous treatment protocols. (b) Sequential treatment protocols. Data points are presented as mean ± SEM. Asterisks (*) denote the statistical significance of changes in cell survival following (Dox-US) protocol compared to (US 48) and (Dox 48) for each cell line. Following (US-Dox) treatment protocol, the cell survival of MES-SA cells decreased significantly compared to (US 48) but was insignificantly increased compared to (Dox 48). In MES-SA/DX5 cells, cell survival was unchanged. However, (US-Dox) protocol showed consistently large difference between the percentages obtained from WST-8 and cell counting assays indicating the presence of cells contributing to viability below the size threshold for detection by the cell counter.